Calmare Therapeutics Incorporated filed its 10-K on Jul 21, 2017 for the period ending Dec 31, 2016. In this report its auditor, Mayer Hoffman McCann P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.